Weaker demand in Europe and Japan saw revenue from Charles River Laboratories' animal models business decline in Q3, but Argenta and BioFocus boosted discovery sales.
Contract research company ChanTest has acquired fellow US firm Applied Clinical Sciences, a specialist in the development of drugs that affect G-protein coupled receptors (GPCR), one of the most fertile areas of drug discovery.
A company that specialises in designing first-in-class small
molecule drugs that modulate ion channels has been given an award
for its innovative preclinical research.
Pharma firms can now follow US regulator's recommendations for
testing the cardiac safety of drug candidates more fully - thanks
to a new addition to Millipore's services.
Researchers have developed a biochip that could prove crucial in
future drug development. The technology measures electrical
activities of cells and can obtain 60 times more data in one
reading than is possible with current technology.
Boehringer Ingelheim has extended its joint drug discovery
collaboration with Evotec initiated in September 2004, which
targeted therapeutics acting on G-Protein Coupled Receptors
(GPCRs). The extension will include targets from different...
Cresset Biomolecular Discovery has launched a technology that
identifies the 3-dimensional bound conformation of hits and
potential drugs in a biological target, assisting scientists
involved in ion channel research.
Microcomponent manufacturer, thinXXS, has launched a novel
microfluidic device which combines microprocessing, micromolding
and circuit board technology to integrate more functions than other
lab-on-a-chip products on the market today.
Sweden's Cellectricon has launched a new microfluidic chip product
that promises to speed up the screening of drugs that interact with
ion channels, an important drug target that make up around 15 per
cent of all medicines on...
German biotech company flyion has developed a new technology which
speeds up drug development and could reduce the number of animals
needed in research.
